Cargando…

Model-based cost-effectiveness analysis of B-type natriuretic peptide-guided care in patients with heart failure

OBJECTIVE: Monitoring B-type natriuretic peptide (BNP) to guide pharmacotherapy might improve survival in patients with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF). However, the cost-effectiveness of BNP-guided care is uncertain and guidelines do not u...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mohiuddin, Syed, Reeves, Barnaby, Pufulete, Maria, Maishman, Rachel, Dayer, Mark, Macleod, John, McDonagh, Theresa, Purdy, Sarah, Rogers, Chris, Hollingworth, William
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2016
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5223729/ https://www.ncbi.nlm.nih.gov/pubmed/28031211 http://dx.doi.org/10.1136/bmjopen-2016-014010

Ejemplares similares

The healthcare costs of heart failure during the last five years of life: A retrospective cohort study
por: Hollingworth, William, et al.
Publicado: (2017)

Protocol for a systematic review and individual participant data meta-analysis of B-type natriuretic peptide-guided therapy for heart failure
por: Pufulete, Maria, et al.
Publicado: (2014)

B-type natriuretic peptide-guided therapy for heart failure (HF): a systematic review and meta-analysis of individual participant data (IPD) and aggregate data
por: Pufulete, Maria, et al.
Publicado: (2018)

‘Off pump’ self-expanding injectable tissue valves (IPVR) versus ‘on pump’ conventional tissue valves (PVR) for replacement of the pulmonary valve: trial protocol for a randomised controlled trial (InVITe trial)
por: Heys, Rachael, et al.
Publicado: (2019)

Developing a UK registry to investigate the role of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway: a multicentre, feasibility study linking routinely collected electronic patient data
por: Brierley, Rachel C, et al.
Publicado: (2018)

Cardiovascular magnetic resonance in emergency patients with multivessel disease or unobstructed coronary arteries: a cost-effectiveness analysis in the UK
por: Stokes, Elizabeth A, et al.
Publicado: (2019)

Formal consensus to identify clinically important changes in management resulting from the use of cardiovascular magnetic resonance (CMR) in patients who activate the primary percutaneous coronary intervention (PPCI) pathway
por: Pufulete, Maria, et al.
Publicado: (2017)

Natriuretic peptide biomarkers in the imminent development of preeclampsia
por: Marek-Iannucci, Stefanie, et al.
Publicado: (2023)

Transient Receptor Potential Channels, Natriuretic Peptides, and Angiotensin Receptor-Neprilysin Inhibitors in Patients With Heart Failure
por: Ding, Kun, et al.
Publicado: (2022)

Impact of the degree of worsening renal function and B-type natriuretic peptide on the prognosis of patients with acute heart failure
por: Zhao, Dongfang, et al.
Publicado: (2023)

SAT-080 Dexamethasone Administration Stimulates Acute Increases in Natriuretic Peptides in Humans: A Potential Diagnostic Test for "Natriuretic Peptide Hormone Deficiency"?
por: Bachmann, Katherine, et al.
Publicado: (2019)

B-type natriuretic peptide and N-terminal Pro-B-type natriuretic peptide in severe aortic stenosis: a comprehensive literature review
por: Cavalcante, Pâmela Nogueira, et al.
Publicado: (2023)

N-Terminal Pro-B-Type Natriuretic Peptide in Risk Stratification of Heart Failure Patients With Implantable Cardioverter-Defibrillator
por: Deng, Yu, et al.
Publicado: (2022)

Comprehensive ascertainment of bleeding in patients prescribed different combinations of dual antiplatelet therapy (DAPT) and triple therapy (TT) in the UK: study protocol for three population-based cohort studies emulating ‘target trials’ (the ADAPTT Study)
por: Pufulete, Maria, et al.
Publicado: (2019)

Prognostic Value of N-Terminal Pro-B-Type Natriuretic Peptide and Glomerular Filtration Rate in Patients With Acute Heart Failure
por: Wang, Kai, et al.
Publicado: (2020)

Association between plasma B-type natriuretic peptide and anaemia in heart failure with or without ischaemic heart disease: a retrospective study
por: Tominaga, Mitsutoshi, et al.
Publicado: (2019)

Prognostic Significance of B-Type Natriuretic Peptide in Patients With Left Ventricular Thrombus
por: An, Zhixia, et al.
Publicado: (2021)

Natriuretic Peptides in Chronic Heart Failure
por: Brunner-La Rocca, Hans-Peter, et al.
Publicado: (2019)

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Natriuretic peptide receptor-3 underpins the disparate regulation of endothelial and vascular smooth muscle cell proliferation by C-type natriuretic peptide
por: Khambata, Rayomand S, et al.
Publicado: (2011)

Hypoxia exposure and B‐type natriuretic peptide release from Langendorff heart of rats
por: Anttila, K., et al.
Publicado: (2016)

B‐type natriuretic peptide‐guided treatment for heart failure
por: McLellan, Julie, et al.
Publicado: (2016)

Diagnostic value of plasma C-type natriuretic peptide levels in determination of the duration of mesenteric ischaemia
por: Demirtas, Sinan, et al.
Publicado: (2014)

The Predictive Value of N-Terminal Probrain Natriuretic Peptide for Infection in Patients With Acute Myocardial Infarction
por: Dai, YiNing, et al.
Publicado: (2021)

Association of serum N-terminal pro-brain natriuretic peptide levels with survival and renal outcomes among elderly patients with acute kidney injury in chronic heart failure
por: Hou, Jiebin, et al.
Publicado: (2023)

Association of N-Terminal Pro-brain Natriuretic Peptide With Volume Status and Cardiac Function in Hemodialysis Patients
por: Wang, Yaqiong, et al.
Publicado: (2021)

Prognosis Implication of N-Terminal Pro-B-Type Natriuretic Peptide in Adult Patients With Acute Myocarditis
por: Zhao, Yan, et al.
Publicado: (2022)

Prognostic value of N-terminal Pro–B-Type natriuretic peptide in patients with intermediate coronary lesions
por: Song, Chenxi, et al.
Publicado: (2022)

Sex and N-terminal pro B-type natriuretic peptide: The potential mediating role of iron biomarkers
por: Khatami, Farnaz, et al.
Publicado: (2022)

Palliative Care in Acute Heart Failure
por: Beattie, James M., et al.
Publicado: (2020)

Predicting the outcome of hip fracture patients by using N-terminal fragment of pro-B-type natriuretic peptide
por: Nordling, Pauliina, et al.
Publicado: (2016)

The proposed role of plasma NT pro-brain natriuretic peptide in assessing cardiac remodelling in hypertensive African subjects
por: Ojji, Dike B, et al.
Publicado: (2014)

Prognostic Value of Natriuretic Peptides for All-Cause Mortality, Right Ventricular Failure, Major Adverse Events, and Myocardial Recovery in Advanced Heart Failure Patients Receiving a Left Ventricular Assist Device: A Systematic Review
por: Janssen, Eva, et al.
Publicado: (2021)

C-Reactive Protein and N-Terminal Pro-brain Natriuretic Peptide Levels Correlate With Impaired Cardiorespiratory Fitness in Patients With Heart Failure Across a Wide Range of Ejection Fraction
por: van Wezenbeek, Jessie, et al.
Publicado: (2018)

Independent and joint association of N-terminal pro-B-type natriuretic peptide and left ventricular mass index with heart failure risk in elderly diabetic patients with right ventricular pacing
por: Yu, Yu, et al.
Publicado: (2022)

A longitudinal study to assess the frequency and cost of antivascular endothelial therapy, and inequalities in access, in England between 2005 and 2015
por: Hollingworth, William, et al.
Publicado: (2017)

Heart Failure Epidemiology: European Perspective
por: Guha, K, et al.
Publicado: (2013)

The potential value of integrated natriuretic peptide and echo-guided heart failure management
por: Scali, Maria Chiara, et al.
Publicado: (2014)

Essential components in natriuretic peptide-guided management of heart failure: an intervention synthesis
por: Oke, Jason, et al.
Publicado: (2018)

RF32 | PSUN60 Bioactive Natriuretic Peptides Measured By Mass Spectrometry and Associations With BMI, Race, and Metabolic Markers
por: Palacios, Julia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_9t5gch6cl6ifgpb7ff8ojodg5u